US Patent Issued to Curie on Aug. 25 for "Immobilized proteases for activation of the zymogen form of transglutaminase" (North Carolina, Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,059, issued on Aug. 25, was assigned to Curie Co. Inc. (Durham, N.C.).

"Immobilized proteases for activation of the zymogen form of transglutaminase" was invented by Erika M. Milczek (Durham, N.C.), Robert Dicosimo (Doylestown, Pa.), Steven Walsh (Durham, N.C.) and Malcolm McCray (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Immobilized proteases for activation of the zymogen form of transglutaminase are disclosed."

The patent was filed on Sept. 9, 2022, under Application No. 17/930,965.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&...